Is Acrivon Therapeutics, Inc. technically bullish or bearish?

As of 9 September 2025, the technical trend for Acrivon Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The RSI shows a bullish signal on the monthly timeframe, but no signal on the weekly. Bollinger Bands are bullish weekly but mildly bearish monthly. Daily moving averages are mildly bearish, and the KST is bearish weekly with no monthly signal. Dow Theory shows no trend weekly and mildly bullish monthly. OBV is bullish in both weekly and monthly perspectives.
In terms of performance, Acrivon has outperformed the S&P 500 over the past week and month, with returns of 7.74% and 20.14% respectively, while the S&P 500 returned 1.05% and 2.33%. However, year-to-date and one-year returns are significantly negative at -72.26% and -77.91%, compared to the S&P 500's positive returns of 12.22% and 17.14%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals across different indicators and longer-term performance challenges.